Status:
UNKNOWN
Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis
Lead Sponsor:
Dr mohammedRmadan hamad
Collaborating Sponsors:
Assiut University
Conditions:
Cmv Colitis
Eligibility:
All Genders
18-75 years
Brief Summary
Aim of the work * To identify the prevalence of CMV infection in patients with steroid-refractory ulcerative colitis. * To assess the clinical and endoscopic conditions in these patients.
Detailed Description
Ulcerative colitis (UC) is a chronic inflammatory disorder of the colonic mucosa characterized by recurrent attacks of bloody diarrhea, abdominal cramping and mucosal ulceration that often requires lo...
Eligibility Criteria
Inclusion
- All eligible patients have an established diagnosis of ulcerative colitis, including clinical, endoscopic and histologic assessments. Eligible patients have moderately to severely active disease (total Mayo score, 6 - 12 points), with endoscopy subscore of at least 2 and had inadequate response to or cannot tolerate treatment with at least one of the following: corticosteroids and/or azathioprine or 6-mercaptopurine and/or 5-aminosalicylate-containing medications.
Exclusion
- \- Patients with remittent UC
- Patients known to have IBD other than ulcerative colitis
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03467841
Start Date
August 1 2018
End Date
September 1 2019
Last Update
March 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.